Cardiology

Nonadherence to statins plus ACEIs/ARBs risky post MI

(HealthDay)—Nonadherence to angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs) and/or statins following acute myocardial infarction (AMI) is associated with higher mortality, according ...

Cardiology

ACEI/ARBs up AMI outcomes regardless of renal status

(HealthDay)—For acute myocardial infarction (AMI) survivors, angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) treatment is associated with improved long-term survival, according to research ...

Diseases, Conditions, Syndromes

Medication improves measure of kidney disease in patients with diabetes

Among patients with diabetes and kidney disease, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of the medication finerenone compared with placebo resulted in improvement ...

Diseases, Conditions, Syndromes

Generic heart disease medications offer promise for Ebola treatment

Generic medications used frequently in the management of heart disease patients also have the potential to bolster the immune systems of patients with Ebola virus and some other life-threatening illnesses, researchers report ...

Diseases, Conditions, Syndromes

High-value research of 2014 presented for peri-op medicine

(HealthDay)—Articles relating to perioperative cardiac medicine, perioperative β-blocker use, perioperative pulmonary medicine, venous thromboembolism prophylaxis, and perioperative medication management are included in ...

Neuroscience

Drug combo slows heart decline in muscular dystrophy

Early use of available heart failure drugs slows the progressive decline in heart function before symptoms are apparent in boys and young men with Duchenne muscular dystrophy (DMD), according to a new study published online ...

page 8 from 12